| Date Filed | Type | Description |
| 08/07/2023 |
8-K
| Quarterly results |
| 07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/28/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/13/2023 |
SC 13G
| Schindel Yair Chaim reports a 6% stake in Akoya Biosciences, Inc. |
| 06/12/2023 |
4
| Ek John Frederick (CFO) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 20,000 shares
@ $5, valued at
$100k
|
|
| 06/12/2023 |
4
| LAI GOLDMAN MYLA (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 20,000 shares
@ $5, valued at
$100k
|
|
| 06/12/2023 |
4
| Mendel Scott (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 20,000 shares
@ $5, valued at
$100k
|
|
| 06/12/2023 |
4
| Winkler Matthew (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 203,388 shares
@ $5, valued at
$1M
|
|
| 06/12/2023 |
4
| SHEPLER ROBERT G (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 120,000 shares
@ $5, valued at
$600k
|
|
| 06/12/2023 |
4
| Raffin Thomas A. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 20,000 shares
@ $5, valued at
$100k
Bought 196,627 shares
@ $5, valued at
$983.1k
Bought 1,803,373 shares
@ $5, valued at
$9M
|
|
| 06/12/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 06/09/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 06/07/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 06/07/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"2 Akoya Disclaimer Disclaimer Akoya Biosciences, Inc. has filed a registration statement with the Securities Exchange Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, including the preliminary prospectus supplement, and other documents the Company has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, copies of the preliminary prospectus supplement and the accompanying prospectus may be obtained by contacting Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, by phone at 1-866-718-1649 or by ..." |
|
| 06/06/2023 |
4
| McKelligon Brian (President/CEO) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 5,000 shares
@ $5.7074, valued at
$28.5k
Exercised 5,000 options to buy
@ $0.303, valued at
$1.5k
|
|
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/05/2023 |
4
| Winkler Matthew (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| LAI GOLDMAN MYLA (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| Raffin Thomas A. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| Mendel Scott (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| SHEPLER ROBERT G (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| SCHNETTLER THOMAS P (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/01/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/08/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/20/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/20/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
|